Annovis Bio, Inc. (ANVS) Deep Dive Video
Summary
An oral, multi-protein Alzheimer’s/Parkinson’s bet with a 2047 patent runway—priced like failure, valued like a breakthrough if Phase 3 hits.
View ANVS stock page · Read the ANVS research report
Loading the video player…